OmicsBox 4.0 adds cloud integration, advanced transcriptomics tools like gene co-expression, and AI-powered summaries ...

The global multiomics market, valued at $3.41 billion in 2025, is forecast to reach $12.82 billion by 2036, growing at a 13.31% CAGR from 2026 to 2036. Growth is driven by precision medicine, ...

Nucleai, a leader in AI-powered tissue intelligence, today announced expanded access to its multimodal spatial analytics platform, through a partnership with the University of Glasgow’s Spatial ...

True three-dimensional (3D) spatial biology provides a more physiologically relevant view of tissue biology and cellular interactions than conventional single-cell or two-dimensional (2D) thin-tissue ...

Background Pancreatic ductal adenocarcinoma (PDAC) is largely refractory to immune checkpoint blockade, owing to its ...

Algenomics, a company specializing in the development of RNA-based gene therapies, announced on July 15 that it has signed a ...

Researchers examining human heart tissue removed during transplant surgery have found that diabetes does not simply raise the ...

Aqtual, Inc., a precision medicine company developing active chromatin cell-free DNA (cfDNA) diagnostics, today announced the appointments of Ferhan Qureshi as Chief Technology Officer and Bill Arteca ...

Scientists are paying increasing attention to pollution that comes from vehicle tires. Unlike exhaust emissions, tiny ...

The U.S. Single-Cell Sequencing Market is projected to grow from USD 1.05 Billion in 2025 to USD 4.07 Billion by 2035, while ...

Why These 3 Large Caps Are Bucking the August Slump Evotec (NASDAQ:EVO) reported preliminary unaudited results for the second ...

Environmental health research is increasingly recognizing the profound influence of complex, lifelong exposures—such as chemical pollutants, dietary ...